青光眼的治疗目标与评估

降低眼压是目前惟一经证实可控且有效的青光眼治疗方式，对眼压的控制已成为检验或评估青光眼治疗是否有效的标志，目标眼压即靶眼压的设定，是实现个体化治疗的主要指标。在降低眼压达到目标眼压的同时，还应注意眼压的波动以及潜在的视神经保护治疗。应根据视神经及视野损害进展情况不断调整或再评估目标眼压。阻止视功能损害进一步加重、保存有用视力、提高生活质量是青光眼治疗的目标。（眼科，2013，22：220-223）

Therapeutic target and its evaluation in glaucoma

Currently, the only approach proven to be efficient in treating glaucoma is lowering the intraocular pressure (IOP). IOP reduction is a remarkable mark to assess the glaucoma treatment. Target IOP is the main indicator of glaucoma individualization treatment. Besides lowering IOP to the target IOP, we should also pay attention to the IOP fluctuation and neuroprotection treatment. The target IOP should be adjusted or re-evaluated following the monitoring of optic nerve structure and visual function progression. The ultimate goal of glaucoma treatment is to prevent the visual function from deterioration, maintain patients’ visual acuity and enhance their quality of life. (Ophthalmol CHN, 2013, 22: 220-223)